A Neurologist and a Mom Join Forces: the Real-World Evidence in the Fight for NurOwn's Approval for People with ALS

A Neurologist and a Mom Join Forces: the Real-World Evidence in the Fight for NurOwn's Approval for People with ALS

The Real-World Evidence in the Citizens' Petition Supports the Accelerated Approval of the Stem Cell Therapy that Was Helping People with ALS Live Longer and Breathe Better

CNM-Au8 in Amyotrophic Lateral Sclerosis

To the Editor A recent study reported that CNM-Au8 did not demonstrate a significant effect in slowing the progression of amyotrophic lateral sclerosis (ALS) at 24 weeks.

Late-Breaking Phase 2b PARADIGM Data Support Continued Development of PrimeC in ALS

Recently reported phase 2b results revealed that PrimeC consistently altered ALS-related miRNA expression, reinforcing its potential as a multi-targeted therapy and aligning with previously reported clinical benefits.